TrialDrugs2025

Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer's Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial.

Susan Abushakra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.